Viewing Study NCT03182166


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-05-08 @ 10:41 AM
Study NCT ID: NCT03182166
Status: COMPLETED
Last Update Posted: 2022-03-14
First Post: 2017-05-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None golimumab View
None clinical response View
None mayo score View
None rectosigmoidoscopy View
None ulcerative colitis View